Source MS Society: The Medicines and Healthcare products Regulatory Agency (MHRA), and European Commission (EC) have licenced ofatumumab to treat adults with active relapsing MS.
We are delighted that Henriette has written a guest blog post for us and also a link to her new blog in Denmark.
We are very sorry we have had to close BMSTC to our members at this difficult time. Whilst we hate to disappoint, the health and wellbeing of our members, volunteers and staff must be our top priority. We will continue to respond based on the advice given by the government and public health authorities.